Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Diabetes gliclazide released in 40mg dose

  • 1 Comment

A gliclazide for type 2 diabetes has been launched for the first time in a 40mg dose.

The product, launched under the name Zircon by Bristol Laboratories, allows patients to titrate up from the lowest possible dose without have to break 80mg tablets in half, which they previously had to do.

  • 1 Comment

Readers' comments (1)

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs